Seeking male & females 16 years or older who are Hematopoietic Stem Cell Transplant (HSCT) recipients with asymptomatic Cytomegalovirus (CMV) infections
The main goal of this study is to see if the study drug works to clear CMV infections from the blood in stem cell transplant recipients with a CMV infection.
What we're hoping for
We are hoping that the study might give information that will help other people with CMV.
ClinicalTrials.gov Identifier: NCT02927067